BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 33526510)

  • 1. Host-Derived Matrix Metalloproteinase-13 Activity Promotes Multiple Myeloma-Induced Osteolysis and Reduces Overall Survival.
    Lo CH; Shay G; McGuire JJ; Li T; Shain KH; Choi JY; Fuerst R; Roush WR; Knapinska AM; Fields GB; Lynch CC
    Cancer Res; 2021 May; 81(9):2415-2428. PubMed ID: 33526510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinase (MMP)-13 regulates mammary tumor-induced osteolysis by activating MMP9 and transforming growth factor-beta signaling at the tumor-bone interface.
    Nannuru KC; Futakuchi M; Varney ML; Vincent TM; Marcusson EG; Singh RK
    Cancer Res; 2010 May; 70(9):3494-504. PubMed ID: 20406980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinase 13 (MMP13) is a direct target of osteoblast-specific transcription factor osterix (Osx) in osteoblasts.
    Zhang C; Tang W; Li Y
    PLoS One; 2012; 7(11):e50525. PubMed ID: 23185634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective inhibition of matrix metalloproteinase-2 in the multiple myeloma-bone microenvironment.
    Shay G; Tauro M; Loiodice F; Tortorella P; Sullivan DM; Hazlehurst LA; Lynch CC
    Oncotarget; 2017 Jun; 8(26):41827-41840. PubMed ID: 28611279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple myeloma-derived exosomes are enriched of amphiregulin (AREG) and activate the epidermal growth factor pathway in the bone microenvironment leading to osteoclastogenesis.
    Raimondo S; Saieva L; Vicario E; Pucci M; Toscani D; Manno M; Raccosta S; Giuliani N; Alessandro R
    J Hematol Oncol; 2019 Jan; 12(1):2. PubMed ID: 30621731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple myeloma-derived MMP-13 mediates osteoclast fusogenesis and osteolytic disease.
    Fu J; Li S; Feng R; Ma H; Sabeh F; Roodman GD; Wang J; Robinson S; Guo XE; Lund T; Normolle D; Mapara MY; Weiss SJ; Lentzsch S
    J Clin Invest; 2016 May; 126(5):1759-72. PubMed ID: 27043283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of osteoclast differentiation and collagen antibody-induced arthritis by CTHRC1.
    Jin YR; Stohn JP; Wang Q; Nagano K; Baron R; Bouxsein ML; Rosen CJ; Adarichev VA; Lindner V
    Bone; 2017 Apr; 97():153-167. PubMed ID: 28115279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis of bone disease in multiple myeloma: from bench to bedside.
    Terpos E; Ntanasis-Stathopoulos I; Gavriatopoulou M; Dimopoulos MA
    Blood Cancer J; 2018 Jan; 8(1):7. PubMed ID: 29330358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-cell contact between marrow stromal cells and myeloma cells via VCAM-1 and alpha(4)beta(1)-integrin enhances production of osteoclast-stimulating activity.
    Michigami T; Shimizu N; Williams PJ; Niewolna M; Dallas SL; Mundy GR; Yoneda T
    Blood; 2000 Sep; 96(5):1953-60. PubMed ID: 10961900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow-derived mesenchymal cells and MMP13 contribute to experimental choroidal neovascularization.
    Lecomte J; Louis K; Detry B; Blacher S; Lambert V; Bekaert S; Munaut C; Paupert J; Blaise P; Foidart JM; Rakic JM; Krane SM; Noel A
    Cell Mol Life Sci; 2011 Feb; 68(4):677-86. PubMed ID: 20700625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomes play a role in multiple myeloma bone disease and tumor development by targeting osteoclasts and osteoblasts.
    Faict S; Muller J; De Veirman K; De Bruyne E; Maes K; Vrancken L; Heusschen R; De Raeve H; Schots R; Vanderkerken K; Caers J; Menu E
    Blood Cancer J; 2018 Nov; 8(11):105. PubMed ID: 30409995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bruton tyrosine kinase inhibition is a novel therapeutic strategy targeting tumor in the bone marrow microenvironment in multiple myeloma.
    Tai YT; Chang BY; Kong SY; Fulciniti M; Yang G; Calle Y; Hu Y; Lin J; Zhao JJ; Cagnetta A; Cea M; Sellitto MA; Zhong MY; Wang Q; Acharya C; Carrasco DR; Buggy JJ; Elias L; Treon SP; Matsui W; Richardson P; Munshi NC; Anderson KC
    Blood; 2012 Aug; 120(9):1877-87. PubMed ID: 22689860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MMP13-Overexpressing Mesenchymal Stem Cells Enhance Bone Tissue Formation in the Presence of Collagen Hydrogel.
    Arai Y; Lee SH
    Tissue Eng Regen Med; 2023 Jun; 20(3):461-471. PubMed ID: 37041434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCR4
    Goto Y; Aoyama M; Sekiya T; Kakita H; Waguri-Nagaya Y; Miyazawa K; Asai K; Goto S
    Stem Cells; 2016 Nov; 34(11):2733-2743. PubMed ID: 27339271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of matrix metalloproteinase 13 in both endochondral and intramembranous ossification during skeletal regeneration.
    Behonick DJ; Xing Z; Lieu S; Buckley JM; Lotz JC; Marcucio RS; Werb Z; Miclau T; Colnot C
    PLoS One; 2007 Nov; 2(11):e1150. PubMed ID: 17987127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological aspects of altered bone remodeling in multiple myeloma and possibilities of pharmacological intervention.
    Kupisiewicz K
    Dan Med Bull; 2011 May; 58(5):B4277. PubMed ID: 21535989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effects of osteoblasts and increased bone formation on myeloma in novel culture systems and a myelomatous mouse model.
    Yaccoby S; Wezeman MJ; Zangari M; Walker R; Cottler-Fox M; Gaddy D; Ling W; Saha R; Barlogie B; Tricot G; Epstein J
    Haematologica; 2006 Feb; 91(2):192-9. PubMed ID: 16461303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stromal matrix metalloprotease-13 knockout alters Collagen I structure at the tumor-host interface and increases lung metastasis of C57BL/6 syngeneic E0771 mammary tumor cells.
    Perry SW; Schueckler JM; Burke K; Arcuri GL; Brown EB
    BMC Cancer; 2013 Sep; 13():411. PubMed ID: 24010522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stem cell abnormalities in patients with multiple myeloma.
    Garderet L; Mazurier C; Chapel A; Ernou I; Boutin L; Holy X; Gorin NC; Lopez M; Doucet C; Lataillade JJ
    Leuk Lymphoma; 2007 Oct; 48(10):2032-41. PubMed ID: 17917971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cathepsin G enhances mammary tumor-induced osteolysis by generating soluble receptor activator of nuclear factor-kappaB ligand.
    Wilson TJ; Nannuru KC; Futakuchi M; Sadanandam A; Singh RK
    Cancer Res; 2008 Jul; 68(14):5803-11. PubMed ID: 18632634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.